Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
about
Does GATA3 act in tissue-specific pathways? A meta-analysis-based approachCD 9 and vimentin distinguish clear cell from chromophobe renal cell carcinoma.The Stanford Tissue Microarray DatabaseThe calcium-binding protein S100P in normal and malignant human tissuesActivation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal models.Heterarchy of transcription factors driving basal and luminal cell phenotypes in human urothelium.S100P: a novel therapeutic target for cancer.GATA3 in the urinary bladder: suppression of neoplastic transformation and down-regulation by androgensHSD3B and gene-gene interactions in a pathway-based analysis of genetic susceptibility to bladder cancer.GATA-3 expression in trophoblastic tissues: an immunohistochemical study of 445 cases, including diagnostic utilityFXYD3: A Promising Biomarker for Urothelial Carcinoma.Decreased expression of the GATA3 gene is associated with poor prognosis in primary gastric adenocarcinomaNew miRNA profiles accurately distinguish renal cell carcinomas and upper tract urothelial carcinomas from the normal kidneyExpression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrenceThe Urinary Bladder Transcriptome and Proteome Defined by Transcriptomics and Antibody-Based ProfilingA perspective on DNA microarrays in pathology research and practiceUtility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung.PAX8 (+)/p63 (-) immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tractClinical significance of T-bet, GATA-3, and Bcl-6 transcription factor expression in bladder carcinoma.GATA3 Expression in Normal Skin and in Benign and Malignant Epidermal and Cutaneous Adnexal Neoplasms.Differential Immunohistochemical Profiles for Distinguishing Prostate Carcinoma and Urothelial Carcinoma.Loss of GATA3 in bladder cancer promotes cell migration and invasion.GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas.GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors.Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development.Diagnostic utility of p63/P501S double sequential immunohistochemical staining in differentiating urothelial carcinoma from prostate carcinoma.The Novel Marker GATA3 is Significantly More Sensitive Than Traditional Markers Mammaglobin and GCDFP15 for Identifying Breast Cancer in Surgical and Cytology Specimens of Metastatic and Matched Primary Tumors.Urothelial Superior Vena Cava Syndrome with Limited Response to Radiation TherapySilencing of GATA3 defines a novel stem cell-like subgroup of ETP-ALL.TERT promoter mutation status in sarcomatoid urothelial carcinomas of the upper urinary tract.Expressional profiles of transcription factors in the progression of Helicobacter pylori-associated gastric carcinoma based on protein/DNA array analysis.DDX39 acts as a suppressor of invasion for bladder cancer.Gene microarray analysis of human renal cell carcinoma: the effects of HDAC inhibition and retinoid treatment.Differential diagnosis of bladder versus colorectal adenocarcinoma: keratin 7 and GATA3 positivity in nuclear ß-catenin-negative glandular tumours defines adenocarcinoma of the bladder.GATA3 is a sensitive marker for primary genital extramammary paget disease: an immunohistochemical study of 72 cases with comparison to gross cystic disease fluid protein 15.Molecular typing for detection of high-risk human papillomavirus is a useful tool for distinguishing primary bladder carcinoma from secondary involvement of uterine cervical carcinoma in the urinary bladder.GATA3 interacts with and stabilizes HIF-1α to enhance cancer cell invasiveness.GATA-binding protein 3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistry.Simultaneous immunostaining with anti-S100P and anti-SV40 antibodies revealed the origin of BK virus-infected decoy cells in voided urine samples.GATA3 immunohistochemical expression in salivary gland neoplasms
P2860
Q24658279-F9F32738-F214-48FF-82D5-FCC428AF69DEQ30891820-CB17F086-89C8-4989-BCD9-F8778A93CA1FQ33305327-55501C2E-6915-47C4-BD41-874AE0438F63Q33320214-E0605966-158C-4E4D-A8C6-C7AD6EBDD454Q33511579-1A9AE151-D6CB-4933-B72B-A4F978604EC5Q33652158-83FD0FD1-CAE2-4610-86C5-5E7559EF8524Q33699305-66475F92-4B31-4CE7-A604-E865A8A78291Q34178465-9F21D9B5-D367-4650-AFA0-B63A4C270B1FQ34320612-99879346-EFB8-4441-917C-C53DC1E7FD0CQ34714508-44D5437E-EAF0-4AC4-BAF5-20E43252D5F3Q34788904-0CBCC1F0-62B0-4C2F-A668-35B4BD04D477Q35087772-C29CD2C0-B379-45CB-8BDB-3A0F7AD2CEDAQ35118634-79211281-1663-4E4B-A882-4402B6842788Q35799910-B0CC1457-8C45-4A08-8873-61D391A0C879Q35875521-9007A62F-FE53-45D9-8AEA-846E7597B90DQ35916012-24532BE3-58CF-4CDD-BB9A-C23853CCEE15Q36240960-B15FFEAB-4910-43D0-A05D-9DE5FA9EA9C7Q36421311-B789AC83-D8EB-48AE-AD80-4E5BEABDC732Q36947101-4D262D65-DABE-4AC1-AEF6-C73F8C568EC5Q36973436-6050DCBA-83DC-4B09-B19C-FE6FED91A0B3Q37297806-61E9564A-C106-4F76-8485-E433ED9BB198Q37692460-47E4F36B-784A-4DC5-A20B-7361E9CAD093Q37709554-B6C34F45-0C12-4321-8DED-A52D89BD707AQ37709857-C19AFEA6-8C2D-444F-B701-6516291A1F5FQ38220806-5BDC2FAE-3C33-4927-8170-3C45C5AF2E2AQ38269382-E815CD92-91A9-47C0-BB1E-E7C757BFD64BQ38438463-06C3E3EA-B5A4-43D1-9CFE-E793A6D974D8Q38658274-06E2DCB7-8802-45A9-9BB3-420B0F7D23CDQ38744314-510FE032-22BD-4215-A69A-DE0C3C1F913AQ38774845-4270DB1E-E8E0-446D-8629-E2C49CFC1DEFQ38819810-7B9ECEAD-9C55-43CD-8747-F4BF48D06108Q39366011-5313AB1A-4BD3-4315-A963-F4DD0C34E7D8Q39943631-F8C1B503-49A8-4A7C-AC57-9FF11E020902Q40435708-1B157E7A-811E-45C4-BED6-B717754045F2Q40978489-8254C303-35C0-40C3-A889-1ECAEA2A2D61Q41119112-3C8E4527-00F8-42ED-8C14-BE7D968A390EQ41193866-781F6CDE-6D78-4934-B805-D9C6CEFAB60BQ41615352-DFAB3C19-F1D0-4850-BB98-850081915590Q41697740-2C71DCC0-CC6E-41E6-84D1-CCA88DA4CAE9Q42078661-13190D70-AA99-45E3-B970-8DADC4B9296D
P2860
Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Placental S100 (S100P) and GAT ...... complementary DNA microarray.
@en
type
label
Placental S100 (S100P) and GAT ...... complementary DNA microarray.
@en
prefLabel
Placental S100 (S100P) and GAT ...... complementary DNA microarray.
@en
P2093
P1476
Placental S100 (S100P) and GAT ...... complementary DNA microarray.
@en
P2093
Gulsah Kaygusuz
James D Brooks
John P T Higgins
Joseph C Presti
Kelli Montgomery
Lingli Wang
Robert J Marinelli
Veronica Mason
P304
P356
10.1097/01.PAS.0000213438.01278.5F
P407
P577
2007-05-01T00:00:00Z